| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.051 | 0.3 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |